Coyote Ventures - Hera Biotech | |
Hera Biotech is developing and commercializing the world’s first non-surgical, tissue-based test to aid definitive diagnosis and staging of endometriosis. This simple test diagnoses endometriosis quickly and less painfully than the current standard, which is invasive surgery. We met Hera Biotech early on in the formation of Coyote Ventures and quickly realized that there was a strong match. Their stellar team was offering a true innovation in the field of endometriosis diagnosis and staging. Hera raised a Seed round to begin their proof-of-concept study and for a pre-submission meeting with the FDA to consider a breakthrough designation for their endometriosis diagnostic. Coyote Ventures is excited to support Hera Biotech with this innovation in women’s health. Since investing, Hera has received the Banner Health Pilot Award, which is significant because Banner is a healthcare payer/provider system that will pilot the test throughout their healthcare system and give Hera its first customer and insurance payer at the same time. | |
Related Link: Click here to visit item owner's website (1 hit) | |
Target State: All States Target City : All Cities Last Update : Apr 05, 2023 3:56 AM Number of Views: 78 | Item Owner : Jessica Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |